| 953 |
934: Decrease, Tetrahydrobiopterin |
932: Uncoupling, eNOS |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 956 |
932: Uncoupling, eNOS |
933: Depletion, Nitric Oxide |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 3014 |
932: Uncoupling, eNOS |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3023 |
932: Uncoupling, eNOS |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 988 |
973: Decrease, AKT/eNOS activity |
933: Depletion, Nitric Oxide |
Nov 29, 2016 |
Oct 16, 2017 |
1 AOP
|
| 958 |
933: Depletion, Nitric Oxide |
937: Impaired, Vasodilation |
Nov 29, 2016 |
Oct 12, 2017 |
1 AOP
|
| 982 |
937: Impaired, Vasodilation |
951: Increase, Vascular Resistance |
Nov 29, 2016 |
Oct 13, 2017 |
1 AOP
|
| 983 |
951: Increase, Vascular Resistance |
952: Hypertension |
Nov 29, 2016 |
Oct 13, 2017 |
1 AOP
|
| 2152 |
1795: TGFbeta expression |
1283: Activation, TGF-beta pathway |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 1778 |
1494: Leukocyte recruitment/activation |
265: Activation, Stellate cells |
Nov 12, 2018 |
Nov 12, 2018 |
1 AOP
|
| 1901 |
1494: Leukocyte recruitment/activation |
1182: Increase, Cell Proliferation (Epithelial Cells) |
May 7, 2019 |
May 7, 2019 |
None
|
| 1905 |
1494: Leukocyte recruitment/activation |
1632: Increase in RONS |
May 7, 2019 |
May 9, 2019 |
2 AOPs
|
| 2891 |
1494: Leukocyte recruitment/activation |
1501: Increased extracellular matrix deposition |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 1728 |
1511: Lipid Peroxidation |
1509: Protein Adduct Formation |
Apr 4, 2018 |
Apr 5, 2018 |
1 AOP
|
| 1731 |
1511: Lipid Peroxidation |
1513: General Apoptosis |
Apr 4, 2018 |
Apr 5, 2018 |
1 AOP
|
| 3377 |
1511: Lipid Peroxidation |
1442: Foam cell formation |
Oct 30, 2024 |
Oct 30, 2024 |
None
|
| 1500 |
1389: Locomotor activity, decreased |
1141: Decreased, Reproductive Success |
May 8, 2017 |
Jun 26, 2017 |
1 AOP
|
| 1705 |
1498: Loss of alveolar capillary membrane integrity |
1499: Activation of Th2 cells |
Jan 5, 2018 |
May 16, 2023 |
1 AOP
|
| 2174 |
1498: Loss of alveolar capillary membrane integrity |
1676: Blood extravasation into the lungs |
Oct 22, 2020 |
Oct 22, 2020 |
None
|
| 2258 |
1498: Loss of alveolar capillary membrane integrity |
1833: Impaired lung function |
Jan 8, 2021 |
Jan 8, 2021 |
None
|
| 2259 |
1498: Loss of alveolar capillary membrane integrity |
1671: Substance - LS interaction |
Jan 8, 2021 |
Jan 8, 2021 |
None
|
| 2368 |
1498: Loss of alveolar capillary membrane integrity |
1672: Inhibition of LS function. |
Apr 27, 2021 |
Apr 27, 2021 |
1 AOP
|
| 2369 |
1498: Loss of alveolar capillary membrane integrity |
1677: Reduced tidal volume |
Apr 27, 2021 |
Apr 27, 2021 |
1 AOP
|
| 2372 |
1498: Loss of alveolar capillary membrane integrity |
1250: Decreased lung function |
Apr 27, 2021 |
Apr 27, 2021 |
1 AOP
|
| 1972 |
1675: Loss of barrier function |
1676: Blood extravasation into the lungs |
Jul 3, 2019 |
Jul 3, 2019 |
None
|